Skip to main content
Article thumbnail
Location of Repository

Investigating the impact of NHS based ovarian cancer screening

By S. M. Nicholson

Abstract

the UK ovarian cancer is the fifth most common cancer in females and after uterine cancer, the second most common gynaecological cancer. There were 6,596 new cases diagnosed in the UK in 2006. The majority of women who develop ovarian cancer have few symptoms until the cancer has spread. A systematic review of published literature was performed to include randomised control trials, case control or cohort studies. It is apparent from the literature on ovarian cancer screening that internationally extensive research is performed however, there is lack of consensus on who to offer screening to, and the most efficacious way of offering it. Annual screening was found to be inadequate for early cancer detection as several studies report advanced stage disease or found that women were developing symptoms in the interim period of screening visits. The retrospective studies performed at Milton Keynes Hospital demonstrated that ovarian cancer affects a wide age range with many women having no family history of ovarian or breast cancer. Many cases were found to have early stage ovarian cancer however, the largest group of women were found to have extensive metastatic disease at time of diagnosis. 80% of cases reviewed experienced abdominal or pelvic pains often with distension. Five patients were found to have a CA125 value in the normal range, one of which had advanced disease, indicating the limitations of this biomarker. The impact and costs associated with screening in the NHS setting vary considerably with inclusion criteria used. The UK National Screening Committee will have to decide once the findings of UKCTOCS are published in 2010/11 as to the cost benefit of offering NHS based ovarian cancer screening. An annual cost of at least £1.3 million should be expected per NHS trust, in addition to individual trusts needs for equipment, staff and additional facilities required to offer such screening

Publisher: Cranfield University
Year: 2010
OAI identifier: oai:dspace.lib.cranfield.ac.uk:1826/6290
Provided by: Cranfield CERES

Suggested articles

Citations

  1. (2000). Benign ovarian cysts and ovarian cancer: A cohort study with implications for screening. doi
  2. (2000). Cancer Biology. 2 nd Edition.
  3. (2009). Cancer Stats, available at: http://info.cancerresearchuk.org/cancerstats/
  4. (2007). Changes in cancer worry associated with participation in ovarian cancer screening. Psycho-oncology, doi
  5. (2004). Clinical, demographic, and psychological characteristics of new, asymptomatic participants in a transvaginal ultrasound screening programme for ovarian cancer. Preventive medicine, doi
  6. (2008). Cochrane Handbook for Systematic Reviews and Interventions, available at: http://www.cochrane-handbook.org/ doi
  7. (2004). combined with transvaginal ultrasonography for ovarian cancer screening.
  8. (2007). Combining multiple serum tumor markers improves detection of stage I epithelial ovarian cancer. Gynecologic oncology, doi
  9. (2004). Compliance of average- and intermediate-risk women to semi-annual ovarian cancer screening. Cancer epidemiology, biomarkers & prevention.,
  10. (2000). Continuing participation supports ultrasound screening for ovarian cancer. doi
  11. (2009). Defining Cancer, available at: http://www.cancer.gov/cancertopics
  12. (2007). Development of an ovarian cancer symptom index: Possibilities for earlier detection. doi
  13. (1995). Early Detection of Ovarian Cancer. doi
  14. (2006). Efficacy of screening women at high risk of hereditary ovarian cancer: Results of an 11-year cohort study. doi
  15. (2005). Efficient screening for ovarian cancers using a combination of tumor markers CA602 and CA546. doi
  16. (2007). Factors associated with return for routine annual screening in an ovarian cancer screening programme. doi
  17. (2007). Feasibility of screening for ovarian cancer using symptoms as selection criteria. doi
  18. (2006). Gene Expression Profiling of Ovarian Tissues for Determination of Molecular Pathways Reflective of Tumorigenesis. doi
  19. (2001). Health-related quality of life and cost-effectiveness studies in the European randomised study of screening for prostate cancer and the US Prostate, Lung, Colon and Ovary trial. doi
  20. (1999). Hereditary Ovarian Carcinoma. doi
  21. (2010). International Federation of Gynaecology and Obstetrics doi
  22. (2005). Learning the Reproductive System, available at:
  23. (2001). Localisation of a Noval Susceptibility Gene for Familial Ovarian Cancer to Chromosome 3p22-p25. doi
  24. (2010). NIHR Health Technology Assessment Programme, available at: http://www.hta.ac.uk/
  25. (2009). Ovarian Cancer - The UK NSC Policy on ovarian cancer screening in women, available at: http://www.screening.nhs.uk/ovariancancer (Accessed 1 st
  26. (2005). Ovarian cancer screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial: findings from the initial screen of a randomized trial. American journal of obstetrics and gynaecology, , doi
  27. (2006). Ovarian cancer screening in women with a family history of breast or ovarian cancer. Obstetrics and gynaecology, , doi
  28. (2007). Ovarian cancer screening with annual transvaginal sonography: Findings of 25,000 women screened. doi
  29. (2003). Ovarian Surface Epithelium: Family History and Early Events in Ovarian Cancer. Reproductive Biology and Endocrinology. doi
  30. (2009). Ovary, Malignant Tumours, available at: http://emedicine.medscape.com/radiology#obgyn.
  31. (2000). Performance of ultrasound as a second line test to serum CA125 in ovarian cancer screening. British journal of obstetrics and gynaecology, doi
  32. (2003). Pre- and postmenopausal high-risk women undergoing screening for ovarian cancer: Anxiety, risk perceptions, and quality of life. doi
  33. (2006). Progress in Biomarker Discovery for Diagnostic Testing in Epithelial Ovarian Cancer. Expert Review of Molecular Diagnostics, doi
  34. (2005). Prospective study using the risk of ovarian cancer algorithm to screen for ovarian cancer.
  35. (2003). Results from an ultrasound-based familial ovarian cancer screening clinic: A 10-year observational study. doi
  36. (2001). Scottish Intercollegiate Guidelines Network - A guideline developers handbook. , available at: www.sign.ac.uk/guidelines/fulltext/50.html (Accessed 1 st
  37. (2009). Screening Committee doi
  38. (2002). Screening for Early Detection. doi
  39. (2005). Screening for familial ovarian cancer: Failure of current protocols to detect ovarian cancer at an early stage according to the International Federation of Gynecology and Obstetrics System.
  40. (2006). Screening for ovarian cancer by transvaginal ultrasound and serum CA125 measurement in women with a familial predisposition: A prospective cohort study. doi
  41. (1999). Screening for ovarian cancer: a pilot randomised controlled trial. doi
  42. (1998). Screening for ovarian cancer: a systematic review. Health Technology Assessment, doi
  43. (2002). Screening for Ovarian Cancer. doi
  44. (2008). Screening Programmes doi
  45. (1999). Serum CA125 elevation and risk of clinical detection of cancer in asymptomatic postmenopausal women. doi
  46. (2009). Statistical Information Team, Cancer Research UK
  47. (2002). Studies Included from SCOPUS Database Search Author and Year of Publication Study Objectives and Study Design SIGN Grading Key Findings Study
  48. The economic impact of false-positive cancer screens.
  49. (2009). The Health and Social Care Information Centre
  50. (2007). The Information Centre for Health and Social Care (2008). Cervical Screening Programme,
  51. (2005). The role of ultrasound evaluation in the detection of early-stage epithelial ovarian cancer. doi
  52. (2005). Three-dimensional ultrasonography and power Doppler in ovarian cancer screening of asymptomatic peri- and postmenopausal women. Croatian medical journal,
  53. (2009). UK Clinical Research Network - UKFOCSS, available at:
  54. (2002). Ultrasound as a possible screening method in ovarian cancer. doi
  55. (2003). Ultrasound screening for the early detection of ovarian cancer. doi
  56. (2005). Use of intensified early cancer detection in high-risk patients with familial breast and ovarian cancer. doi
  57. (2000). Usefulness of mass screening for ovarian carcinoma using transvaginal ultrasonography. doi
  58. (2002). Worry about ovarian cancer risk and use of ovarian cancer screening by women at risk for ovarian cancer. doi

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.